Our people understand the fundamental procedures, issues and initiatives that will have an impact on regulatory success in all of the world’s major markets.

From the start, we focus on the integration of all project leaders and outside advisors and experts to ensure that manufacturing, preclinical and clinical studies comply with both key European and US regulations, while supporting Japan regulations including current good laboratory practice (cGLP) and current good clinical practice (cGCP).